215 related articles for article (PubMed ID: 21742374)
1. Receptor-targeted iron oxide nanoparticles for molecular MR imaging of inflamed atherosclerotic plaques.
Tu C; Ng TS; Sohi HK; Palko HA; House A; Jacobs RE; Louie AY
Biomaterials; 2011 Oct; 32(29):7209-16. PubMed ID: 21742374
[TBL] [Abstract][Full Text] [Related]
2. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
[No Abstract] [Full Text] [Related]
3. Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI.
von zur Muhlen C; Fink-Petri A; Salaklang J; Paul D; Neudorfer I; Berti V; Merkle A; Peter K; Bode C; von Elverfeldt D
Contrast Media Mol Imaging; 2010; 5(5):268-75. PubMed ID: 20973112
[TBL] [Abstract][Full Text] [Related]
4. Scavenger receptor-AI-targeted iron oxide nanoparticles for in vivo MRI detection of atherosclerotic lesions.
Segers FM; den Adel B; Bot I; van der Graaf LM; van der Veer EP; Gonzalez W; Raynal I; de Winther M; Wodzig WK; Poelmann RE; van Berkel TJ; van der Weerd L; Biessen EA
Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1812-9. PubMed ID: 23744990
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of acid-stabilized iron oxide nanoparticles and comparison for targeting atherosclerotic plaques: evaluation by MRI, quantitative MPS, and TEM alternative to ambiguous Prussian blue iron staining.
Scharlach C; Kratz H; Wiekhorst F; Warmuth C; Schnorr J; Genter G; Ebert M; Mueller S; Schellenberger E
Nanomedicine; 2015 Jul; 11(5):1085-95. PubMed ID: 25659644
[TBL] [Abstract][Full Text] [Related]
6. Multimodality PET/MRI agents targeted to activated macrophages.
Tu C; Ng TS; Jacobs RE; Louie AY
J Biol Inorg Chem; 2014 Feb; 19(2):247-58. PubMed ID: 24166283
[TBL] [Abstract][Full Text] [Related]
7. Microdistribution of Magnetic Resonance Imaging Contrast Agents in Atherosclerotic Plaques Determined by LA-ICP-MS and SR-μXRF Imaging.
Uca YO; Hallmann D; Hesse B; Seim C; Stolzenburg N; Pietsch H; Schnorr J; Taupitz M
Mol Imaging Biol; 2021 Jun; 23(3):382-393. PubMed ID: 33289060
[TBL] [Abstract][Full Text] [Related]
8. Scavenger receptor-AI-targeted ultrasmall gold nanoclusters facilitate in vivo MR and ex vivo fluorescence dual-modality visualization of vulnerable atherosclerotic plaques.
Wang J; Wu M; Chang J; Li L; Guo Q; Hao J; Peng Q; Zhang B; Zhang X; Li X
Nanomedicine; 2019 Jul; 19():81-94. PubMed ID: 31028886
[TBL] [Abstract][Full Text] [Related]
9. Macrophage uptake switches on OCT contrast of superparamagnetic nanoparticles for imaging of atherosclerotic plaques.
Ariza de Schellenberger A; Poller WC; Stangl V; Landmesser U; Schellenberger E
Int J Nanomedicine; 2018; 13():7905-7913. PubMed ID: 30538467
[TBL] [Abstract][Full Text] [Related]
10. OxLDL-targeted iron oxide nanoparticles for in vivo MRI detection of perivascular carotid collar induced atherosclerotic lesions in ApoE-deficient mice.
Wen 文颂 S; Liu 柳东芳 DF; Liu 刘振 Z; Harris S; Yao 姚玉宇 YY; Ding 丁琪 Q; Nie 聂芳 F; Lu 卢瞳 T; Chen 陈华俊 HJ; An 安艳丽 YL; Zang 臧凤超 FC; Teng 滕皋军 GJ
J Lipid Res; 2012 May; 53(5):829-838. PubMed ID: 22393161
[TBL] [Abstract][Full Text] [Related]
11. In vivo MRI detection of carotid atherosclerotic lesions and kidney inflammation in ApoE-deficient mice by using LOX-1 targeted iron nanoparticles.
Wen S; Liu DF; Cui Y; Harris SS; Chen YC; Li KC; Ju SH; Teng GJ
Nanomedicine; 2014 Apr; 10(3):639-49. PubMed ID: 24103305
[TBL] [Abstract][Full Text] [Related]
12. Hybrid, metal oxide-peptide amphiphile micelles for molecular magnetic resonance imaging of atherosclerosis.
Poon C; Gallo J; Joo J; Chang T; Bañobre-López M; Chung EJ
J Nanobiotechnology; 2018 Nov; 16(1):92. PubMed ID: 30442135
[TBL] [Abstract][Full Text] [Related]
13. Imaging of the vulnerable carotid plaque: biological targeting of inflammation in atherosclerosis using iron oxide particles and MRI.
Chan JM; Monaco C; Wylezinska-Arridge M; Tremoleda JL; Gibbs RG
Eur J Vasc Endovasc Surg; 2014 May; 47(5):462-9. PubMed ID: 24594295
[TBL] [Abstract][Full Text] [Related]
14. Promoting the Delivery of Nanoparticles to Atherosclerotic Plaques by DNA Coating.
Zhang L; Tian XY; Chan CKW; Bai Q; Cheng CK; Chen FM; Cheung MSH; Yin B; Yang H; Yung WY; Chen Z; Ding F; Leung KC; Zhang C; Huang Y; Lau JYW; Choi CHJ
ACS Appl Mater Interfaces; 2019 Apr; 11(15):13888-13904. PubMed ID: 30516979
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of Iron Oxide-Based Contrast Agents in Rabbit Atherosclerotic Plaques in Relation to Plaque Age and Vulnerability Features.
Sekita A; Unterweger H; Berg S; Ohlmeyer S; Bäuerle T; Zheng KH; Coolen BF; Nederveen AJ; Cabella C; Rossi S; Stroes ESG; Alexiou C; Lyer S; Cicha I
Int J Nanomedicine; 2024; 19():1645-1666. PubMed ID: 38406599
[TBL] [Abstract][Full Text] [Related]
16. Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting.
Cole AJ; David AE; Wang J; Galbán CJ; Hill HL; Yang VC
Biomaterials; 2011 Mar; 32(8):2183-93. PubMed ID: 21176955
[TBL] [Abstract][Full Text] [Related]
17. Intraperitoneal injection improves the uptake of nanoparticle-labeled high-density lipoprotein to atherosclerotic plaques compared with intravenous injection: a multimodal imaging study in ApoE knockout mice.
Jung C; Kaul MG; Bruns OT; Dučić T; Freund B; Heine M; Reimer R; Meents A; Salmen SC; Weller H; Nielsen P; Adam G; Heeren J; Ittrich H
Circ Cardiovasc Imaging; 2014 Mar; 7(2):303-11. PubMed ID: 24357264
[TBL] [Abstract][Full Text] [Related]
18. Activatable fluorescence imaging of macrophages in atherosclerotic plaques using iron oxide nanoparticles conjugated with indocyanine green.
Ikeda H; Ishii A; Sano K; Chihara H; Arai D; Abekura Y; Nishi H; Ono M; Saji H; Miyamoto S
Atherosclerosis; 2018 Aug; 275():1-10. PubMed ID: 29852399
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced MR imaging of atherosclerosis using citrate-coated superparamagnetic iron oxide nanoparticles: calcifying microvesicles as imaging target for plaque characterization.
Wagner S; Schnorr J; Ludwig A; Stangl V; Ebert M; Hamm B; Taupitz M
Int J Nanomedicine; 2013; 8():767-79. PubMed ID: 23450179
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
